Abstract
References
1.
Dahl
J.B.
,
Kehlet
H.
Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative pain. Br J Anaesth 1991 ; 66 : 703 –712 .
2.
Murray
M.D.
,
Brater
D.C.
Renal toxicity of the nonsteroidal antiinflammatory drugs. Annu Rev Pharmacol Toxicol 1993 ; 32 : 435 –65 .
3.
Harris
K.
The role of prsotaglandins in the control of renal function (editorial). Br J Anaesth 1992 ; 69 : 233 –5 .
4.
O'Leary
M.
,
Martin
P.
,
McLean
A.S.
Oliguria and haemorrhage after intramuscular injection of ketoroalc tremetamol (letter). Med J Aust 1993 ; 158 : 719 –20 .
5.
Schoch
P.H.
,
Ranno
A.
,
North
D.S.
Acute renal failure in an elderly woman following intramuscular ketorolac administration. Ann Pharmacother 1992 ; 26 : 1223 –6 .
6.
Fong
J.
,
Gora
M.L.
Reversible renal insufficiency following ketorolac therapy (letter). Ann Pharmacother 1993 ; 27 : 510 –2 .
7.
Boras-Uber
L.A.
,
Brackett
N.C.
Ketorolac-induced acute renal failure (letter). Am J Med 1992 ; 92 : 450 –2 .
8.
Pearce
C.J.
,
Gonzalez
F.M.
,
Wallin
J.D.
Renal failure and hyperkalemia associated with ketorolac tromethamine. Arch Intern Med 1993 ; 153 : 1000 –2 .
9.Reactions Weekly. Adis International , Auckland , 3 July, 1993 .
10.
Choo
V.
,
Lewis
S.
Ketorolac doses reduced. Lancet July 10, 1993 ; 342 : 109 .